Business Segments Vanda Pharmaceuticals Inc.
Equities
VNDA
US9216591084
Biotechnology & Medical Research
|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 7.890 USD | -0.25% |
|
-8.26% | -10.54% |
| 03-05 | Truist Initiates Vanda Pharmaceuticals at Buy With $18 Price Target | MT |
| 03-05 | Vanda Pharmaceuticals Insider Sold Shares Worth $1,276,971, According to a Recent SEC Filing | MT |
Sales 2025 by Business Segment
Sales 2025 by Geography
Historical Breakdown of Revenue by Business Segments
Net Income: Breakdown by Business Segment
| Fiscal Period: December | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
Biological Products | ||||||||||
Biotechnology (Startups) | 269M | 254M | 193M | 199M | 216M | |||||
Total Assets | 594M | 634M | 648M | 656M | 489M | |||||
Income Tax Expense | 9.21M | 5.02M | 3.83M | -4.02M | 81.83M | |||||
CAPEX | -552K | -679K | -101M | -4.72M | -998K | |||||
EBT | 42.36M | 11.3M | 6.34M | -22.92M | -139M | |||||
D&A | 2.84M | 2.73M | 3.01M | 8.13M | 11.92M | |||||
Operating Income | 42.16M | 6.33M | -13.95M | -40.66M | -151M | |||||
Net Income | 33.15M | 6.28M | 2.51M | -18.9M | -220M |
Geographical Revenue Distribution History
| Fiscal Period: December | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
United States | 269M | 254M | 193M | 199M | 216M | |||||
Total Assets | 594M | 634M | 648M | 656M | 489M | |||||
Income Tax Expense | 9.21M | 5.02M | 3.83M | -4.02M | 81.83M | |||||
D&A | 2.84M | 2.73M | 3.01M | 8.13M | 11.92M | |||||
CAPEX | -552K | -679K | -101M | -4.72M | -998K | |||||
Net Income | 33.15M | 6.28M | 2.51M | -18.9M | -220M | |||||
EBT | 42.36M | 11.3M | 6.34M | -22.92M | -139M | |||||
Operating Income | 42.16M | 6.33M | -13.95M | -40.66M | -151M |
- Stock Market
- Equities
- VNDA Stock
- Financials Vanda Pharmaceuticals Inc.
- Business Segments
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition